Sugi Predict

Sugi Predict / Compounds / SCHEMBL466130

SCHEMBL466130

SCHEMBL466130

OC[C@H]1O[C@H]2O[C@H]1[C@H](O)[C@H]2O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 1.00
▸ TSHR P16473 2/20 1.00
▸ LMNA P02545 1/20 1.00
▸ TDP1 Q9NUW8 1/20 1.00
▸ TXNRD1 Q16881 6/20 0.77
▸ TXNRD3 Q86VQ6 6/20 0.77
▸ TXNRD2 Q9NNW7 6/20 0.77
▸ HDAC3 O15379 1/20 0.51
▸ HDAC1 Q13547 1/20 0.51
▸ HDAC2 Q92769 1/20 0.51
▸ HDAC8 Q9BY41 1/20 0.51
▸ HDAC6 Q9UBN7 1/20 0.51
▸ FYN P06241 1/20 0.47
▸ MAOA P21397 1/20 0.47
▸ SLC6A2 P23975 1/20 0.47
▸ HTR2C P28335 1/20 0.47
▸ HTR2B P41595 1/20 0.47
▸ SLC6A3 Q01959 1/20 0.47
▸ LGALS1 P09382 2/20 0.37
▸ LGALS3 P17931 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alfadex SCHEMBL21134960 1.00 ALDH1A1 (1.00) ALDH1A1TSHRLMNATDP1TXNRD1
Gamma-Cyclodextrin SCHEMBL25455463 1.00 ALDH1A1 (1.00) ALDH1A1TSHRLMNATDP1TXNRD1
Betadex SCHEMBL24109285 1.00 ALDH1A1 (1.00) ALDH1A1TSHRLMNATDP1TXNRD1
Gamma-Cyclodextrin SCHEMBL20533920 1.00 ALDH1A1 (1.00) ALDH1A1TSHRLMNATDP1TXNRD1
Gamma-Cyclodextrin SCHEMBL25455531 1.00 ALDH1A1 (1.00) ALDH1A1TSHRLMNATDP1TXNRD1
Alfadex SCHEMBL23188277 1.00 ALDH1A1 (1.00) ALDH1A1TSHRLMNATDP1TXNRD1
Alfadex SCHEMBL24109286 1.00 ALDH1A1 (1.00) ALDH1A1TSHRLMNATDP1TXNRD1
Alfadex SCHEMBL25455476 1.00 ALDH1A1 (1.00) ALDH1A1TSHRLMNATDP1TXNRD1
Betadex SCHEMBL23188251 1.00 ALDH1A1 (1.00) ALDH1A1TSHRLMNATDP1TXNRD1
Gamma-Cyclodextrin SCHEMBL20998969 1.00 ALDH1A1 (1.00) ALDH1A1TSHRLMNATDP1TXNRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240117379-A1 TEMPERATURE-RESPONSIVE VIRUS STORAGE SYSTEM FERRING VENTURES LTD (GB) 2024-04-11 — — US disclosed
US-20240066041-A1 MICROPARTICLES CONTAINING STABILIZED CBD OIL, AND METHODS FOR THE PRODUCTION THEREOF ANABIO TECHNOLOGIES LIMITED (IE) 2024-02-29 — — US disclosed
US-20240043873-A1 TEMPERATURE-RESPONSIVE VIRUS STORAGE SYSTEM FERRING VENTURES LTD (GB) 2024-02-08 — — US disclosed
US-20240043570-A1 MODIFIED STARCHES FOR HOME CARE AND PERSONAL CARE CARGILL, INCORPORATED (US) 2024-02-08 — — US disclosed
US-20240000807-A1 DRY SELF-EMULSIFYING CANNABINOID COMPOSITIONS AND USE THEREOF Technology Holding Company LLC 2024-01-04 — — US disclosed
US-20230354845-A1 HIGHLY CAFFEINATED COCOA-BASED COMPOSITION AND METHODS OF MAKING AND USING THEREOF SEATTLE GUMMY COMPANY (US) 2023-11-09 — — US disclosed
US-11718665-B2 Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins RANI THERAPEUTICS, LLC (US) 2023-08-08 — — US disclosed
US-20230233744-A1 BREAST MILK FILTRATION DEVICE AND METHOD Kaehler Science for Women, LLC 2023-07-27 — — US disclosed
US-20230218657-A1 COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREOF NAT UNIV SINGAPORE (SG) 2023-07-13 — — US disclosed
US-20230175012-A1 TEMPERATURE-RESPONSIVE VIRUS STORAGE SYSTEM FERRING VENTURES LTD (GB) 2023-06-08 — — US disclosed
WO-2010044042-A1 ANTIMICROBIAL COMPOSITIONS MANUKA HEALTH NEW ZEALAND LIMITED (NZ) 2010-04-22 — — WO disclosed
WO-2010033637-A1 DISSOLUTION OF ARTERIAL PLAQUE Z & Z MEDICAL HOLDINGS, INC. (US) 2010-03-25 — — WO disclosed
US-20100040674-A1 CONTROLLED DELIVERY OF BIOACTIVE AGENTS FROM DECOMPOSABLE FILMS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2010-02-18 — — US disclosed
WO-2009126637-A1 ANTIFOLATE COMPOSITIONS CHELSEA THERAPEUTICS, INC. (US) 2009-10-15 — — WO disclosed
US-20090253720-A1 ANTIFOLATE COMPOSITIONS CHELSEA THERAPEUTICS, INC. 2009-10-08 — — US disclosed
US-20090208549-A1 Devices and Methods for Reverse Lipid Transport MEDTRONIC VASCULAR, INC. (US) 2009-08-20 — — US disclosed
WO-2009026014-A1 COMPOSITIONS, SYSTEMS, AND/OR METHODS INVOLVING CHLORINE DIOXIDE ('CIO2') HARRISON KEN (US) 2009-02-26 — — WO disclosed
US-20090054375-A1 Compositions, Systems, and/or Methods Involving Chlorine Dioxide CUROXIN, LLC 2009-02-26 — — US disclosed
US-20090035348-A1 DISSOLUTION OF ARTERIAL PLAQUE Z & Z MEDICAL HOLDINGS, INC. (US) 2009-02-05 — — US disclosed
US-20080176942-A1 Stabilized sulforaphane PHARMAGRA LABS, INC. (US) 2008-07-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100040674-A1 CONTROLLED DELIVERY OF BIOACTIVE AGENTS FROM DECOMPOSABLE FILMS LIPA, ADAM9, TGFB1 ALDH1A1 2655/4885TSHR 4781/4885LMNA 306/4885
US-20090253720-A1 ANTIFOLATE COMPOSITIONS FDFT1, SLC19A1, FIBP ALDH1A1 1831/4885TSHR 3278/4885LMNA 4714/4885
US-20240043570-A1 MODIFIED STARCHES FOR HOME CARE AND PERSONAL CARE GALC, AMY2A, MGAM ALDH1A1 4829/4885TSHR 3551/4885LMNA 2448/4885
US-11718665-B2 Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins VIP, IAPP, GIPR ALDH1A1 4392/4885TSHR 1629/4885LMNA 722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.